Judge: Jaw Plaintiffs Failed to Show They Took Enough, If Any, Bisphosphonates



DOCUMENTS
  • Duncan Opinion
  • Lee Opinion


NASHVILLE, Tenn. - A plaintiff who failed to provide evidence she ever took a bisphosphonate drug, and another who couldn't show that she took enough of the drug for it to cause injury, cannot proceed with claims that they face an increased risk of developing a disfiguring jaw bone disease, a federal judge ruled. In re Aredia and Zometa Products Liability Litigation, MDL No. 1760 (M.D. Tenn.).

Judge Todd J. Campbell of the U.S. District Court for the Middle District of Tennessee issued the separate rulings Nov. 30, determining that each plaintiff failed to establish requisite evidence for showing that …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

October 25, 2024 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

September 25, 2024 - Nashville, TN
Hutton Hotel

MORE DETAILS